Alcohol and Duloxetine: Can You Take Them Together?

High — Consult Your Doctorconflict
Evidence-gradedLast reviewed June 1, 2026Source: FDA Prescribing Information — Cymbalta (duloxetine)
Learn about each ingredient:AlcoholDuloxetine

Quick answer

Duloxetine (Cymbalta) and heavy alcohol use both can damage the liver. The FDA-approved label explicitly states that Cymbalta should not be prescribed to patients with substantial alcohol use because the combination has been linked to severe, sometimes fatal, hepatotoxicity in clinical trial data.

Patients with substantial or daily alcohol use should not take duloxetine. If you are on duloxetine, avoid alcohol entirely, or limit to no more than one standard drink occasionally with prescriber approval. Watch for jaundice, dark urine, abdominal pain, or nausea — stop the drug and seek urgent care.

What happens when you take alcohol with duloxetine?

Duloxetine, sold as Cymbalta, is an SNRI (serotonin-norepinephrine reuptake inhibitor) approved for major depression, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain. Unlike most other SSRIs and SNRIs, the FDA-approved Cymbalta label carries an explicit hepatotoxicity warning tied directly to alcohol use.

In the original duloxetine clinical trial database, three patients developed liver injury with elevated ALT and bilirubin and evidence of biliary obstruction. Substantial concurrent alcohol use was present in each of these cases. Based on this and subsequent post-marketing data, the FDA states: "Cymbalta should not be prescribed to patients with substantial alcohol use or evidence of chronic liver disease." The label warns that concomitant use with heavy alcohol intake may be associated with severe liver injury.

The mechanism appears to be additive hepatotoxic stress. Duloxetine itself causes asymptomatic ALT elevations in a small percentage of patients. Alcohol independently damages hepatocytes. Combining the two appears to substantially raise the risk of clinically significant — sometimes fulminant — liver injury.

Why is this important?

The Cymbalta-alcohol interaction is one of the few SNRI/SSRI interactions where the concern is not just additive sedation but real organ damage. Cases of acute hepatitis, jaundice, and even liver failure requiring transplantation have been reported. Patients who drink heavily or who have any pre-existing liver disease (hepatitis B or C, fatty liver, cirrhosis, prior drug-induced liver injury) are at the highest risk.

Beyond hepatotoxicity, duloxetine and alcohol are both CNS depressants. The combination worsens drowsiness, dizziness, and impaired judgment, increases falls in older adults, and undermines the antidepressant effect. Cymbalta carries the standard antidepressant black box warning for increased suicidality in young people, and alcohol intoxication is one of the strongest acute predictors of suicide attempts.

Duloxetine can also raise blood pressure, increase bleeding risk (via platelet effects), and cause hyponatremia (SIADH). Alcohol independently contributes to all three. The medication is metabolized by CYP1A2 and CYP2D6; chronic heavy drinking can alter hepatic enzyme activity and change duloxetine blood levels unpredictably.

What should you do?

If you drink heavily, daily, or have any history of liver disease, duloxetine is not the right antidepressant for you. Tell your prescriber honestly about your drinking before starting Cymbalta. There are equally effective alternatives (sertraline, escitalopram, venlafaxine, mirtazapine) that do not carry the same hepatotoxicity flag.

If you are already on duloxetine, the safest path is to abstain from alcohol. Occasional light drinking (one standard drink, infrequently) may be acceptable for some patients after discussion with the prescriber, but binge drinking and daily drinking are not safe. Baseline and periodic liver function tests (ALT, AST, alkaline phosphatase, bilirubin) are a reasonable precaution for anyone on duloxetine who drinks at all.

Know the warning signs of liver injury: yellowing of the skin or eyes (jaundice), dark cola-colored urine, pale stools, right upper quadrant abdominal pain, unusual fatigue, persistent nausea, or vomiting. If any of these appear, stop the medication and contact your prescriber or urgent care immediately. Liver injury from duloxetine can be reversible if caught early.

Which specific products are affected?

The warning applies to all duloxetine products: brand-name Cymbalta delayed-release capsules, generic duloxetine capsules, and the brand Drizalma Sprinkle capsules. Doses of 20 mg, 30 mg, 60 mg, 90 mg, and 120 mg daily all carry the same caution.

Alcohol means all ethanol-containing beverages — beer, wine, hard seltzer, spirits, fortified wines, cocktails. "Substantial alcohol use" in the FDA label is generally understood as more than moderate daily intake (more than 1 drink/day for women, more than 2 drinks/day for men) or any binge drinking. Hidden alcohol sources (cold-and-flu syrups, some mouthwashes, kombucha at up to 3% ABV) should also be limited. Other hepatotoxic substances — acetaminophen above recommended doses, kava, comfrey, high-dose green tea extract — should be avoided as well.

The bottom line

Duloxetine's interaction with alcohol is one of the most serious among antidepressants because of documented severe liver injury. The FDA label tells prescribers not to use Cymbalta in patients with substantial alcohol use. If you drink heavily or daily, ask for a different medication. If you are on Cymbalta, avoid alcohol or keep it minimal and rare, get baseline liver tests, and learn the warning signs of hepatic injury so you can act quickly if they appear.

References

Primary evidence for this article. Always consult your healthcare provider for personal medical advice.

Related Interactions

Other interactions you should know about

Duloxetine + St. John's Wort

critical

Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI), and St. John's wort independently raises central serotonin through reuptake inhibition. Combined use can precipitate serotonin syndrome, and St. John's wort induction of CYP3A4 and P-glycoprotein may also alter duloxetine exposure.

Alcohol + Kava

high

Kava and alcohol both depress the central nervous system through GABAergic and other mechanisms, producing additive sedation and motor impairment. More importantly, both substances are hepatotoxic, and concurrent use significantly increases the risk of severe liver injury, including cases of fulminant liver failure requiring transplantation.

Alcohol + Lithium

high

Lithium has a narrow therapeutic window and is excreted by the kidneys. Alcohol causes diuresis and dehydration, which reduces renal lithium clearance and raises serum lithium levels — pushing patients toward lithium toxicity (tremor, confusion, ataxia, arrhythmia). Alcohol also worsens mood instability in bipolar disorder.

Sertraline + St. John's Wort

critical

Sertraline is an SSRI that blocks serotonin reuptake, and St. John's wort independently inhibits serotonin reuptake and contains constituents (hyperforin, hypericin) that elevate central serotonin. Combining them can trigger serotonin syndrome, a potentially life-threatening syndrome of altered mental status, autonomic instability, and neuromuscular hyperactivity. St. John's wort also induces CYP3A4 and CYP2C19, which can lower sertraline plasma levels and undermine treatment.

Venlafaxine + St. John's Wort

critical

Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI). St. John's wort independently inhibits serotonin (and to a lesser extent norepinephrine and dopamine) reuptake. Combining them can drive a sharp rise in synaptic serotonin and trigger serotonin syndrome, and St. John's wort can also alter venlafaxine pharmacokinetics through CYP3A4 induction.

Alcohol + Warfarin

critical

Alcohol affects warfarin in two opposing ways: acute heavy drinking inhibits hepatic CYP2C9 metabolism of warfarin, raising INR and bleeding risk, while chronic heavy drinking induces enzymes that lower INR and increase clot risk. Alcohol also damages the liver and platelets, compounding bleeding hazards.

Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before making changes to your supplement or medication routine. Pilora does not diagnose, treat, cure, or prevent any disease.

Check all your supplement interactions instantly

Try Pilora Free